Assessment of the Safety and Performance of a Compression Ankle Support in the Prevention of Injuries During Sports Practice

NCT ID: NCT04742088

Last Updated: 2022-09-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-17

Study Completion Date

2023-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Decathlon has developed ankleSOFT100 product which is medical device designed to reduce pain and joint instability during sport practice. The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon ankleSOFT100 product to demonstrate safety and performance of this device in a real-world setting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pain Chronic Instability of Ankle Joint

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Orthosis group

Group Type EXPERIMENTAL

ankleSOFT100

Intervention Type DEVICE

During the first two weeks of follow-up, the subject shall not use the device during the sports sessions. The subject shall use the device during the sports sessions for the next 4 weeks (6 weeks of follow-up)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ankleSOFT100

During the first two weeks of follow-up, the subject shall not use the device during the sports sessions. The subject shall use the device during the sports sessions for the next 4 weeks (6 weeks of follow-up)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is aged ≥18 years old
* Subject has chronic pain AND / OR chronic ankle instability
* The current condition of his/her ankle allows the subject to pursue a usual physical activity
* Subject has been informed and is willing to sign an informed consent form
* Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (6 weeks)
* Subject is affiliated to the French social security regime


* Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent
* Subject has worn a support (ankle brace or articulated orthosis) during sports sessions during the last month
* Subject has any medical condition that could impact the study at investigator's discretion
* Subject has a known hypersensitivity or allergy to the components of the device (polyamide, elastodiene, elastane, polyester, synthetic rubber)
* Adult subject to a legal protection measure
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

EFOR, France

INDUSTRY

Sponsor Role collaborator

Decathlon SE

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Valérie WIECZOREK

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Universitaire de Lille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre de rééducation et de balnéothérapie Kinés Faches

Faches-Thumesnil, , France

Site Status ACTIVE_NOT_RECRUITING

Centre Hospitalier Universitaire de Lille

Lille, , France

Site Status RECRUITING

Cabinet de kinésithérapie du Belvédère

Paris, , France

Site Status NOT_YET_RECRUITING

KOSS Paris 8

Paris, , France

Site Status TERMINATED

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jean HEE

Role: CONTACT

XX XX XX XX XX

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Valérie WIECZOREK

Role: primary

Charlotte QUATRHOMME

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ankleSOFT100

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.